358632-25-4
358632-25-4
Chemical Structure
Taprizosin mesylate
Synonym(s): UK-338003 mesylate
- CAS. Nr.: 358632-25-4
- Formula:C26H30N6O7S2
- Molecular Weight:602.68
IUPAC Name: N-(2-(4-amino-6,7-dimethoxy-5-(pyridin-2-yl)quinazolin-2-yl)-1,2,3,4-tetrahydroisoquinolin-5-yl)methanesulfonamide methanesulfonate
InChIKey: PELLFYXDXSYSSE-UHFFFAOYSA-N
SMILES: CS(=O)(NC1=CC=CC2=C1CCN(C3=NC(N)=C4C(C5=NC=CC=C5)=C(OC)C(OC)=CC4=N3)C2)=O.CS(=O)(O)=O
Biological Activity: Taprizosin (UK-338003) mesylate is an α-adrenoreceptor antagonist[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Taprizosin mesylate | Taprizosin (UK-338003) mesylate is an α-adrenoreceptor antagonist. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Collett A, et al. Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): the rational use of ex vivo intestine to predict in vivo absorption. Drug Metab Dispos. 2008 Jan;36(1):87-94. [Content Brief]
